Logo image of ARES

ARES MANAGEMENT CORP - A (ARES) Stock Fundamental Analysis

NYSE:ARES - New York Stock Exchange, Inc. - US03990B1017 - Common Stock - Currency: USD

177.37  -2.76 (-1.53%)

After market: 177.37 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ARES. ARES was compared to 233 industry peers in the Capital Markets industry. Both the profitability and financial health of ARES have multiple concerns. ARES shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ARES was profitable.
In the past year ARES had a positive cash flow from operations.
Each year in the past 5 years ARES has been profitable.
In the past 5 years ARES reported 4 times negative operating cash flow.
ARES Yearly Net Income VS EBIT VS OCF VS FCFARES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

ARES's Return On Assets of 1.31% is on the low side compared to the rest of the industry. ARES is outperformed by 60.09% of its industry peers.
With a Return On Equity value of 7.98%, ARES perfoms like the industry average, outperforming 49.36% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.71%, ARES is in line with its industry, outperforming 47.21% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ARES is below the industry average of 7.84%.
Industry RankSector Rank
ROA 1.31%
ROE 7.98%
ROIC 3.71%
ROA(3y)1.39%
ROA(5y)1.33%
ROE(3y)15.05%
ROE(5y)15.08%
ROIC(3y)3.87%
ROIC(5y)3.61%
ARES Yearly ROA, ROE, ROICARES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ARES has a worse Profit Margin (8.33%) than 63.95% of its industry peers.
In the last couple of years the Profit Margin of ARES has grown nicely.
ARES's Operating Margin of 21.45% is in line compared to the rest of the industry. ARES outperforms 43.35% of its industry peers.
ARES's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.45%
PM (TTM) 8.33%
GM N/A
OM growth 3Y7.41%
OM growth 5Y8.32%
PM growth 3Y6.46%
PM growth 5Y9.3%
GM growth 3YN/A
GM growth 5YN/A
ARES Yearly Profit, Operating, Gross MarginsARES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ARES has more shares outstanding
Compared to 5 years ago, ARES has more shares outstanding
ARES has a better debt/assets ratio than last year.
ARES Yearly Shares OutstandingARES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ARES Yearly Total Debt VS Total AssetsARES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.60, we must say that ARES is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.60, ARES is in the better half of the industry, outperforming 65.24% of the companies in the same industry.
The Debt to FCF ratio of ARES is 3.18, which is a good value as it means it would take ARES, 3.18 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.18, ARES is doing good in the industry, outperforming 75.11% of the companies in the same industry.
A Debt/Equity ratio of 2.84 is on the high side and indicates that ARES has dependencies on debt financing.
ARES has a Debt to Equity ratio of 2.84. This is amonst the worse of the industry: ARES underperforms 82.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.84
Debt/FCF 3.18
Altman-Z 1.6
ROIC/WACCN/A
WACCN/A
ARES Yearly LT Debt VS Equity VS FCFARES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.34 indicates that ARES may have some problems paying its short term obligations.
The Current ratio of ARES (0.34) is worse than 84.12% of its industry peers.
ARES has a Quick Ratio of 0.34. This is a bad value and indicates that ARES is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ARES (0.34) is worse than 84.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
ARES Yearly Current Assets VS Current LiabilitesARES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

9

3. Growth

3.1 Past

ARES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.90%, which is quite good.
Measured over the past years, ARES shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.77% on average per year.
ARES shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.00%.
ARES shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.09% yearly.
EPS 1Y (TTM)13.9%
EPS 3Y15.6%
EPS 5Y18.77%
EPS Q2Q%36.25%
Revenue 1Y (TTM)21%
Revenue growth 3Y-2.66%
Revenue growth 5Y17.09%
Sales Q2Q%25.11%

3.2 Future

The Earnings Per Share is expected to grow by 25.57% on average over the next years. This is a very strong growth
Based on estimates for the next years, ARES will show a very strong growth in Revenue. The Revenue will grow by 22.70% on average per year.
EPS Next Y32.08%
EPS Next 2Y29%
EPS Next 3Y25.57%
EPS Next 5YN/A
Revenue Next Year24.14%
Revenue Next 2Y23.88%
Revenue Next 3Y22.7%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ARES Yearly Revenue VS EstimatesARES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
ARES Yearly EPS VS EstimatesARES Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 41.64 indicates a quite expensive valuation of ARES.
75.54% of the companies in the same industry are cheaper than ARES, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ARES to the average of the S&P500 Index (27.30), we can say ARES is valued expensively.
With a Price/Forward Earnings ratio of 26.85, ARES can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ARES indicates a slightly more expensive valuation: ARES is more expensive than 65.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, ARES is valued a bit more expensive.
Industry RankSector Rank
PE 41.64
Fwd PE 26.85
ARES Price Earnings VS Forward Price EarningsARES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARES indicates a somewhat cheap valuation: ARES is cheaper than 61.37% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ARES is valued a bit cheaper than the industry average as 67.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.53
EV/EBITDA 64.9
ARES Per share dataARES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ARES's earnings are expected to grow with 25.57% in the coming years.
PEG (NY)1.3
PEG (5Y)2.22
EPS Next 2Y29%
EPS Next 3Y25.57%

5

5. Dividend

5.1 Amount

ARES has a Yearly Dividend Yield of 2.52%.
ARES's Dividend Yield is comparable with the industry average which is at 8.10.
Compared to an average S&P500 Dividend Yield of 2.37, ARES has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.52%

5.2 History

The dividend of ARES has a limited annual growth rate of 5.80%.
ARES has been paying a dividend for at least 10 years, so it has a reliable track record.
As ARES did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)5.8%
Div Incr Years5
Div Non Decr Years5
ARES Yearly Dividends per shareARES Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

ARES pays out 403.92% of its income as dividend. This is not a sustainable payout ratio.
The dividend of ARES is growing, but earnings are growing more, so the dividend growth is sustainable.
DP403.92%
EPS Next 2Y29%
EPS Next 3Y25.57%
ARES Yearly Income VS Free CF VS DividendARES Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B
ARES Dividend Payout.ARES Dividend Payout, showing the Payout Ratio.ARES Dividend Payout.PayoutRetained Earnings

ARES MANAGEMENT CORP - A

NYSE:ARES (7/11/2025, 8:04:00 PM)

After market: 177.37 0 (0%)

177.37

-2.76 (-1.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-05 2025-05-05/bmo
Earnings (Next)08-01 2025-08-01/bmo
Inst Owners80.27%
Inst Owner Change0%
Ins Owners3%
Ins Owner Change3.41%
Market Cap57.93B
Analysts78.26
Price Target183.87 (3.66%)
Short Float %3.4%
Short Ratio4.16
Dividend
Industry RankSector Rank
Dividend Yield 2.52%
Yearly Dividend4.22
Dividend Growth(5Y)5.8%
DP403.92%
Div Incr Years5
Div Non Decr Years5
Ex-Date06-16 2025-06-16 (1.12)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.93%
Min EPS beat(2)-7.09%
Max EPS beat(2)12.95%
EPS beat(4)1
Avg EPS beat(4)0.83%
Min EPS beat(4)-7.09%
Max EPS beat(4)12.95%
EPS beat(8)3
Avg EPS beat(8)-0.69%
EPS beat(12)5
Avg EPS beat(12)-0.36%
EPS beat(16)7
Avg EPS beat(16)1.83%
Revenue beat(2)1
Avg Revenue beat(2)1.05%
Min Revenue beat(2)-4.32%
Max Revenue beat(2)6.42%
Revenue beat(4)2
Avg Revenue beat(4)8.9%
Min Revenue beat(4)-4.6%
Max Revenue beat(4)38.08%
Revenue beat(8)4
Avg Revenue beat(8)11.25%
Revenue beat(12)6
Avg Revenue beat(12)9.99%
Revenue beat(16)10
Avg Revenue beat(16)30.51%
PT rev (1m)5.21%
PT rev (3m)-8.67%
EPS NQ rev (1m)-0.36%
EPS NQ rev (3m)-9.3%
EPS NY rev (1m)0.13%
EPS NY rev (3m)-1.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.02%
Valuation
Industry RankSector Rank
PE 41.64
Fwd PE 26.85
P/S 13.58
P/FCF 14.53
P/OCF 14.21
P/B 13
P/tB N/A
EV/EBITDA 64.9
EPS(TTM)4.26
EY2.4%
EPS(NY)6.61
Fwd EY3.72%
FCF(TTM)12.21
FCFY6.88%
OCF(TTM)12.48
OCFY7.04%
SpS13.06
BVpS13.64
TBVpS-4.05
PEG (NY)1.3
PEG (5Y)2.22
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 7.98%
ROCE 4.26%
ROIC 3.71%
ROICexc 4.05%
ROICexgc 6.15%
OM 21.45%
PM (TTM) 8.33%
GM N/A
FCFM 93.48%
ROA(3y)1.39%
ROA(5y)1.33%
ROE(3y)15.05%
ROE(5y)15.08%
ROIC(3y)3.87%
ROIC(5y)3.61%
ROICexc(3y)4.28%
ROICexc(5y)3.97%
ROICexgc(3y)4.93%
ROICexgc(5y)4.55%
ROCE(3y)4.44%
ROCE(5y)4.15%
ROICexcg growth 3Y1.38%
ROICexcg growth 5Y15.46%
ROICexc growth 3Y1.72%
ROICexc growth 5Y12.7%
OM growth 3Y7.41%
OM growth 5Y8.32%
PM growth 3Y6.46%
PM growth 5Y9.3%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 2.84
Debt/FCF 3.18
Debt/EBITDA 11.8
Cap/Depr 55.12%
Cap/Sales 2.05%
Interest Coverage 250
Cash Conversion 379.52%
Profit Quality 1121.77%
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z 1.6
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)32.4%
Cap/Depr(5y)31.97%
Cap/Sales(3y)1.79%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.9%
EPS 3Y15.6%
EPS 5Y18.77%
EPS Q2Q%36.25%
EPS Next Y32.08%
EPS Next 2Y29%
EPS Next 3Y25.57%
EPS Next 5YN/A
Revenue 1Y (TTM)21%
Revenue growth 3Y-2.66%
Revenue growth 5Y17.09%
Sales Q2Q%25.11%
Revenue Next Year24.14%
Revenue Next 2Y23.88%
Revenue Next 3Y22.7%
Revenue Next 5YN/A
EBIT growth 1Y1.55%
EBIT growth 3Y4.56%
EBIT growth 5Y26.83%
EBIT Next Year54.93%
EBIT Next 3Y33.01%
EBIT Next 5YN/A
FCF growth 1Y1490.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1725.64%
OCF growth 3YN/A
OCF growth 5YN/A